Community Oncology Alliance


 

2021 Update on Targeting Pathways in Frontline CLL: BTK Resistance, Efficacy Data on BCL-2, CD20, and PI3K Inhibitors

21 views
June 4, 2021
Comments 0
Login to view comments. Click here to Login